10. Musculoskeletal and Joint Diseases
| First line drugs | Second line drugs | Specialist drugs | Secondary care drugs |
| Recommended in both primary and secondary care | Alternatives (often in specific conditions) in both primary and secondary care; | Where a specialist input is needed (see introduction for definition) | Prescribing principally within secondary care only |
- 10.1.1 Non–steroidal anti–inflammatory drugs
- 10.1.2 Corticosteroids
- 10.1.3 Drugs which suppress the rheumatic disease process
- 10.1.4 Gout and cytotoxic–induced hyperuricaemia
- 10.1.5 Other drugs for rheumatic diseases
- 10.2.1 Drugs which enhance neuromuscular transmission
- 10.2.2 Skeletal muscle relaxants
- 10.3.1 Enzymes
- 10.3.2 Rubefacients and other topical antirheumatics
- Other products
Last updated by: Carol Webb on 22-08-2011 09:57
Please click on the links below for more information
-
BNF
-
NICE
-
Summary of product characteristics
